Engineered Enzymes to Break Extracellular Crosslinks - Aaron Cravens at Longevity Summit Dublin 2024

[@greenstar2108]

I can imagine the general public becoming less obvlivious (or dismissive) of longevity research when they see the results of de-aging human skin. Presumably breaking the crosslinks is one of the most important factors in achieving such a result? (I'm not a biologist, just a scum bag mathematician who came across the channel :-) ).

[@richardnunziata3221]

The one issue I have with this conference is after discounting all those efforts to treat diseases of aging once the disease embedded there is very little left to talk about concerning aging. There is some but not as much as you would think for a conference like this, and most of it is still in mouse or worm studies.

[@comradecapybara]

you typically need a disease to target in order to get through FDA approval quickly and cheaply, showing that a given therapy cures a disease is a lot easier to prove then something that effects aging more broadly but doesn't effect any one disease enough to demonstrate efficacy.

[@richardnunziata3221]

Running out of time so questions and answer period is skipped is a red flag